dihexa resistant to peptidases Peptide Therapy: Brain & Memory Support Dihexa (PNB-0408) | c-Met/HGFR Activator

doi: 10.1136/gut.2005.065557

[DOI] [PubMed] [Google Scholar] 109.Bailey S.P., Zacher C.M., Mittleman K.D

Our peptides are backed by verified COA, ensuring researchers can trust in their efficacy and safety

Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials

TPE is performed under the care of a licensed medical provider and monitored by healthcare professionals